Cingulate Inc. Share Price
CINGCingulate Inc. Stock Performance
Open $4.66 | Prev. Close $4.67 | Circuit Range N/A |
Day Range $4.66 - $4.97 | Year Range $3.19 - $11.78 | Volume 14,358 |
Average Traded $4.84 |
Cingulate Inc. Share Price Chart
About Cingulate Inc.
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company develops medications capable of once-daily dosing using its proprietary drug delivery platform technology, Precision Timed Release. Its drug candidates include CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials, as well as CTx-1302 (dextroamphetamine), which is in Phase 1/2 clinical pharmacology and Phase 3 clinical efficacy and safety trials for the treatment of ADHD in children, adolescents, and adults; and CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and related disorders. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Cingulate Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
10-Jun-26 | $4.66 | $4.88 | +0.00% |
10-Jun-26 | $4.66 | $4.88 | +7.62% |
08-Jun-26 | $4.60 | $4.53 | +0.89% |
05-Jun-26 | $4.56 | $4.49 | -6.65% |
04-Jun-26 | $4.77 | $4.81 | -1.84% |
03-Jun-26 | $4.08 | $4.90 | +20.25% |
02-Jun-26 | $3.58 | $4.08 | +13.51% |
FAQs on Cingulate Inc. Share Price
Can I buy Cingulate Inc. shares in India?
What is the share price of Cingulate Inc.?
What is the 5 year returns of Cingulate Inc.?
What are the high & low stock price of Cingulate Inc. today?
What is the 52-week high and low of Cingulate Inc. stock?